Ruth Dovdavany

Ruth Dovdavany is an accomplished pharmaceutical marketing leader with extensive experience in brand strategy and commercialization. Currently serving as the Global Commercial Lead for ARIKAYCE at Insmed Incorporated since January 2021, Ruth Dovdavany is accountable for the global brand strategy and success of the product. Previously, Ruth Dovdavany held the position of Executive Director and ARIKAYCE Brand Leader at Pfizer and served as Vice President of Marketing for the Eucrisa Brand Team. Ruth Dovdavany's prior experience also includes roles at Novartis and Pfizer, where significant accomplishments include leading the U.S. launch of Eliquis and the launch of Entresto for Chronic Heart Failure patients. Ruth Dovdavany began their career in investment banking and health care management consulting, and holds an MBA from Harvard Business School and a BA from Brown University.